ArticleFrontiers in oncology2025
MRI-based deep transfer learning models for predicting progesterone receptor expression in meningioma.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- A scoping review of artificial intelligence applications in meningioma from image analysis to prognostic prediction.Discover oncology · 2026Review
- MRI and Meningioma Research: Hotspots and Trends via Bibliometric AnalysisCurrent medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The progesterone receptor (PR) is an important biomarker in meningiomas, influencing tumor growth, prognosis, and potential treatment options. The objective of this study was to predict PR expression in meningioma via deep transfer learning (DTL). Methods: A total of 307 patients were included in the study, including 173 positive patients and 134 negative patients. The clinical features were analyzed. The DTL features were extracted via the fine-tuned ResNet 50 model and selected by the intraclass correlation coefficient (ICC), spearman correlation coefficient and least absolute shrinkage and selection operator (LASSO). The predictive models were built via logistic regression (LR), support vector machine (SVM) and naive Bayes. The discriminative ability of the model was assessed by receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC). The accuracy, sensitivity and specificity were also calculated. Decision curve analysis (DCA) curves were drawn to evaluate the clinical usefulness of the nomogram. Results: A total of 2048 DTL features were extracted, and 35 features were selected for model construction. In the test set, the AUCs of the LR, naive Bayes, and SVM models were 0.819 (95% CI: 0.7081-0.9300), 083(95% CI: 0.7216-0.9376), and 0.842 (95% CI: 0.7359-0.9488), respectively. There was no significant difference between any two models according to the Delong test. The SVM model exhibited a greater net benefit across the highest probability according to the DCA curve. Conclusions: The SVM model achieved better predictive performance and represents a useful tool for evaluating meningioma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.